CCR6 and colitis: However, it is widely acknowledged that different phenotypes may ensue from targeting a protein function, either via small molecule inhibitors or gene knock out [30]: accordingly, the fact that CCR6 deficiency via gene knockout of donor T cells aggravates colitis in the T cell adoptive transfer model does not univocally mean that CCR6 antagonists would worsen colitis.